(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded ...

Patients report that GLP-1 drugs like Ozempic and Mounjaro reduce “food noise,” the constant mental chatter about eating.

Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at ...

Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

Despite carbohydrates being an essential macronutrient, when it comes to weight loss, carbs like pasta, rice, corn, bread and ...

Basil seeds, known for their weight loss properties, are enhanced when combined with ingredients like lemon juice, honey, ...

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.

New research reveals men and women process breakfast nutrients differently, reshaping weight loss strategies with a focus on ...